^
Association details:
Biomarker:No biomarker
Cancer:Merkel Cell Carcinoma
Drug:topotecan (Topoisomerase I inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
Source:
Published date:
10/02/2019
Excerpt:
Merkel Cell Carcinoma: Preferred regimen...Useful in certain circumstances as clinical judgment dictates for patients with contraindications to checkpoint immunotherapy...Topotecan